In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 7th, 2005 | 21 | Yes |
Popular Name: Hydromorphone Hydromorphone
(-)-(5R)-4,5-Epoxy-3-hydroxy-9alpha-methylmorphinan-6-one
(5alpha)-3-hydroxy-17-methyl-4,5-epoxymorphinan-6-one
3-hydroxy-17-methyl-4,5alpha-epoxymorphinan-6-one
4,5-Epoxy-3-hydroxy-17-methylmorphinan-6-one
4,5alpha-Epoxy-3-hydroxy-17-methyl-6-morphinanone
466-99-9; C07042; Hydromorphone
466-99-9; D08047; Hydromorphone (INN)
6-Deoxy-7,8-dihydro-6-oxomorphine
71-68-1; D00839; Dilaudid (TN); Exalgo (TN); Hydromorphone hydrochloride (USP); Palladone (TN)
hidromorfona; hydromorphone; hydromorphonum
Hydromorphone Hydrochloride (FDA
Morphinan-6-one, 4,5-alpha-epoxy-3-hydroxy-17-methyl-
Morphinan-6-one, 4,5-epoxy-3-hydroxy-17-methyl-, (5alpha)-
Morphinan-6-one, 4,5alpha-epoxy-3-hydroxy-17-methyl-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.42 | -0.9 | -61.65 | 2 | 4 | 1 | 50 | 286.351 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 4.39e+00 g/l | DrugBank-approved |
UniProt Database Links | COR11_PAPSO; COR12_PAPSO; COR13_PAPSO; COR14_PAPSO; COR15_PAPSO | ChEBI |
Patent Database Links | EP0908186; EP1504758; EP1518555; EP1535615; EP1557179; EP1584335; EP1600154; EP1604666; EP1604667; EP1639997; EP1685839; EP1700601; EP1741426; EP1767221; EP1776950; EP1797883; EP1813276; EP1815846; EP1820805; EP1829527; EP1829528; EP1834634; EP1849460; EP | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 38 | 0.49 | Binding ≤ 10μM |
OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 3 | 0.57 | Binding ≤ 10μM |
OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 3 | 0.57 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 38 | 0.49 | Binding ≤ 1μM |
OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 11 | 0.53 | Binding ≤ 1μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.28 | 0.64 | Binding ≤ 1μM |
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 38 | 0.49 | Binding ≤ 10μM |
OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 11 | 0.53 | Binding ≤ 10μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.28 | 0.64 | Binding ≤ 10μM |
Description | Species |
---|---|
G alpha (i) signalling events | |
G-protein activation | |
Opioid Signalling | |
Peptide ligand-binding receptors |